Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotictumor lysate

References

• Dighiero G, Travade P, Chevret S. B cell chronic lymphocytic leukemia: present status and future directions. French Co-operative Group on CLL. Blood 1991; 78: 1901–1914
   PubMed Web of Science ®Google Scholar
• Dighiero G, Binet J L. When and how to treat chronic lymphocytic leukemia. New Engl J Med 2000; 343: 1799–1801
   PubMed Web of Science ®Google Scholar
• Goddard R V, Prentice A G, Copplestone J A. Generation of in vitro B-cell chronic lymphocytic leukemia-proliferative and specific HLA class-II-restricted cytotoxic T cell responses using autologous dendritic cells pulsed with tumor cell lysate. Clin Exp Immunol 2001; 126: 16–28
   PubMed Web of Science ®Google Scholar
• Rezvany M R, Jeddi-Tehrani M, Rabbani H. Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukemia. Br J Haematol 2000; 111: 608–617
   PubMed Web of Science ®Google Scholar
• Trojan A, Shultze J L, Witzens M. Immunoglobulin frame work-derived peptides function as cytotoxic T cell epitopes commonly expressed in B cell malignancies. Nat Med 2000; 6: 667–672
   PubMed Web of Science ®Google Scholar
• Gitelson E, Hammond C, Mena J. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines. Clin Cancer Res 2003; 9: 1656–1665
   PubMed Web of Science ®Google Scholar
• Vuillier F, Maloum K, Thomas E K. Idiotype pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukemia. Br J Haematol 2003; 120: 243–250
   PubMed Web of Science ®Google Scholar
• Goddard R V, Prentice A G, Copplestone J A. In vitro dendritic cell induced T cell responses to B-cell chronic lyphocytic leukemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids. Clin Exp Immunol 2003; 131: 82–89
   PubMed Web of Science ®Google Scholar
• Kokhaei P, Rezvani M R, Virving L. Dendritic cells loaded with apoptotic tumor cells induce a stronger T cell response than dendritic cell-tumor hybrids in B-CLL. Leukemia 2003; 5: 894–899
   Web of Science ®Google Scholar
• Wendtner C M, Kohler D M, Theiss H D. Efficient transfer of CD40 ligand in to primary B-CLL cells using recombinant adeno-associated virus (rAAv) vectors. Blood 2002; 100: 1655–1661
   PubMed Web of Science ®Google Scholar
• Wierda W G, Cantwell M J, Woods S J. CD40 ligand (CD154) gene therapy or chronic lymphocytic leukemia. Blood 2000; 96: 2917–2924
   PubMed Web of Science ®Google Scholar
• Battle T E, Wierda W G, Rassenti L Z. In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response. Clin Cancer Res 2003; 9: 2166–2172
   PubMed Web of Science ®Google Scholar
• Chu P, Deforce D, Pederson I M. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 3854–3859
   PubMed Web of Science ®Google Scholar
• Krackhardt A M, Harig S, Witzens M. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy. Blood 2002; 100: 167–173
   PubMed Web of Science ®Google Scholar
• Ranheim E A, Kipps T J. Tumor necrosis factor alpha initiate induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10 and CD40L. Cell Immunol 1995; 161: 226–235
   PubMed Web of Science ®Google Scholar
• Buhmann R, Nolte A, Westhaus D. CD40-activated B-cell chronic lymphocytic leukemia cells for tumour immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cell. Blood 1999; 93: 1992–2002
   PubMed Web of Science ®Google Scholar
• Orsini E, Guarini A, Chiaretti S. The circulating Dendritic cell compartment in patients with Chronic Lymphocytic Leukemia is severely defective and unable to stimulate an effective T cell response. Cancer Res 2003; 63: 4497–4506
   PubMed Web of Science ®Google Scholar
• Romano C, De Fanus U, Sellitto A. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells. Leuk Lymphoma 2003; 44: 1963–1971
   PubMed Web of Science ®Google Scholar
• Scrivner S, Goddard R V, Kaminski E R, Prentice A G. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk Lymphoma 2003; 44: 383–389
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman R M. Dendritic cells and control of immunity. Nature 1998; 392: 245–252
   PubMed Web of Science ®Google Scholar
• Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9: 10–16
   PubMed Web of Science ®Google Scholar
• Banchereau J, Briere F, Caux C. Immunobiology of dendritic cells. Ann Rev Immunol 2000; 18: 767–811
   PubMed Web of Science ®Google Scholar
• Rezvany M R, Jedda-Tehrani M, Biberfeld P. Dendritic cells in patients with non-progressive B-Chronic lymphocytic leukemia have a normal functional capability but abnormal cytokine pattern. Br J Haematol 2001; 115: 263–271
   PubMed Web of Science ®Google Scholar
• Albert M L, Pearce S FA, Francisco L M. Immature dendritic cells phagocytose apoptotic cells via alpha and beta and CD36 and cross present antigen to cytotoxic T lymphocytes. J Exp Med 1998; 188: 1359–1368
   PubMed Web of Science ®Google Scholar
• Caux C, Massacrier B, Vanbervliet B. Activation of human Denditic cells through CD40 cross- linking. J Exp Med 1994; 180: 1263–1272
   PubMed Web of Science ®Google Scholar
• Cella M, Schiedegger K, Palmer-Lehmann P. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity T-T help via APC activation. J Exp Med 1996; 184: 747–752
   PubMed Web of Science ®Google Scholar
• Vegh Z, Mazumdar A. Generation of tumor lysate-loaded dendritic cells preprogrammed for IL-12 production and augmented T cell response. Cancer Immunol Immunother 2003; 52: 67–79
   PubMed Web of Science ®Google Scholar
• Chakroborty N G, Sporn J R, Tortora J R. Immunisation with tumor cell lysate-loaded autologous antigen presenting cell based vaccine in melanoma. Cancer Immunol Immunother 1998; 47: 58–64
   PubMed Web of Science ®Google Scholar
• Geiger J D, Hutchinson R J, Hohenkirk L F. Vaccination of pediatric solid tumor patients with tumor lysate pulsed dendritic cells can expand specific T cells and mediate tumorregression. Cancer Res 2001; 61: 8513–8519
   PubMed Web of Science ®Google Scholar
• Hsu F J, Benike C, Fagnoni F. Vaccination of patients with B cell lymphoma using autologous antigen pulsed dendritic cells. Nature Med 1996; 2: 52–58
   PubMed Web of Science ®Google Scholar
• Binet J L, Auquier A, Dighiero G. A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Grever M. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Strome S E, Voss S, Wilcox R. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 2002; 62: 1884
   PubMed Web of Science ®Google Scholar
• Suresh K, Fraser G, Scheid E, Leber B, Gauldie J, Foley R. Induction of specific immunity to B-CLL cells by in vitro stimulation using antigen pulsed autologous dendritic cells. Blood 2003; 102: 11, Abstract # 1600.
   Google Scholar
• Thumann P, Moc I, Humrich J, Berger T G, Schultze E S, Schuler G, Jenne L. Antigen loading of dendritic cells with whole tumor cell preparations. J Immunol Methods 2003; 277: 1–16
   PubMed Web of Science ®Google Scholar
• Hoogendum M, Olde Wolbers J, Smit W M, Schafsma M R. Generation of B-cell chronic lymphocytic leukemia(B-CLL)-reactive T cell lines and clones from HLA class-I matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy. Leukemia 2004; 18: 1278–1287
   PubMed Web of Science ®Google Scholar
• Rossi E, Matutes E, Morila R. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia 1996; 10: 494–497
   PubMed Web of Science ®Google Scholar
• Kneitz C, Goller M, Wilhelm M. Inhibition of T cell/B cell interaction by B-CLL cells. Leukemia 1999; 13: 98–104
   PubMed Web of Science ®Google Scholar